1. Home
  2. AUGX

AUGX

Augmedix Inc.

Logo Augmedix Inc.

Technology

Computer Software: Prepackaged Software

Nasdaq

as 04-19-2024 2:17pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SAN FRANCISCO
Market Cap: 145.7M IPO Year: N/A
Target Price: $5.38 AVG Volume (30 days): 374.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.44 EPS Growth: N/A
52 Week Low/High: $1.50 - $6.25 Next Earning Date: 05-10-2024
Revenue: $44,855,000 Revenue Growth: 45.01%
Revenue Growth (this year): 38.66% Revenue Growth (next year): 38.78%

Share on Social Networks:

Stock Insider Trading Activity of Augmedix Inc. (AUGX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Shakil Ian AUGX CHIEF STRATEGY OFFICER Apr 15 '24 Sell $3.80 500 $1,900.00 3,000 SEC Form 4
Shakil Ian AUGX CHIEF STRATEGY OFFICER Apr 12 '24 Sell $3.82 19,544 $74,589.68 3,000 SEC Form 4
Shakil Ian AUGX CHIEF STRATEGY OFFICER Apr 1 '24 Sell $3.89 51,346 $199,684.59 187,666 SEC Form 4
Shakil Ian AUGX CHIEF STRATEGY OFFICER Apr 1 '24 Sell $4.02 7,632 $30,698.96 180,034 SEC Form 4
Shakil Ian AUGX CHIEF STRATEGY OFFICER Apr 1 '24 Sell $3.89 38,463 $149,724.92 141,571 SEC Form 4